ResMed | RMD - Market Capitalization



ResMed reported $40.67B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
AtriCure USD 1.62B 25M Jun/2025
Baxter International USD 15.54B 2.02B Jun/2025
Cochlear AUD 18.97B 2.79B Dec/2024
Cooper Companies USD 13.45B 649M Sep/2025
CSL AUD 136.34B 6.32B Dec/2024
Dexcom USD 34.23B 7.45B Jun/2025
Edwards Lifesciences USD 45.88B 3.27B Jun/2025
Fisher Paykel Healthcare NZD 21.66B 2.09B Sep/2025
Globus Medical USD 7.99B 1.92B Jun/2025
Haemonetics USD 3.55B 352M Jun/2025
Hologic USD 14.52B 659M Jun/2025
Idexx Laboratories USD 43.13B 9.1B Jun/2025
Insulet USD 22.11B 3.63B Jun/2025
Integra LifeSciences USD 954M 745M Jun/2025
Intuitive Surgical USD 194.77B 17.33B Jun/2025
Masimo USD 9.12B 118M Jun/2025
Philips EUR 19.65B 2.33B Jun/2025
Ramsay Health Care AUD 7.95B 2.95B Dec/2024
ResMed USD 37.83B 4.95B Jun/2025
Steris USD 23.63B 1.36B Jun/2025
Teleflex USD 5.23B 940M Jun/2025
Thermo Fisher Scientific USD 154.12B 33.72B Jun/2025